Science Blog

Science news straight from the oven

Navigation

  • Topics
    • Aerospace
    • Animals
    • Anthro and Archaeology
    • Bio and Medicine
    • Brain and Behavior
    • Business and Economy
    • Computers and Electronics
    • Education and Outreach
    • Energy and Environment
    • Geoscience
    • Internet and Communication
    • Media and Entertainment
    • Nanotech, Chem and Materials
    • Physics and Numbers
    • Security and Defense
    • Software
    • Space
    • Transportation
  • Reader Blogs
  • Commerce
  • Register/Login
Home Topics Bio and Medicine
  • Contact
  • Home
Google

Similar entries

  • Vaccine for herpes in final trial phase
  • Success of herpes vaccine builds momentum for human trials
  • Cannabis may help combat cancer-causing herpes viruses
  • Screening for Genital Herpes Should be Targeted

Recent Comments

  • Moving to a related discussion
  • ‘Round and ‘round you go
  • why such a zero content comment
  • Who Sleep With You
  • older women
more

Reader Blogs

  • Spectra of gravitational waves
  • Did you know that?
  • Fun with digits
  • AFFiRiS: Milestone Reached in Clinical Trial of Alzheimer’s Vaccine
more

Research holds promise for herpes vaccine

A study by a Montana State University researcher suggests a new avenue for developing a vaccine against genital herpes and other diseases caused by herpes simplex viruses.

In a study published earlier this year in the Virology Journal, MSU virologist William Halford showed that mice vaccinated with a live, genetically-modified herpes simplex virus type 1 (HSV-1) showed no signs of disease 30 days after being exposed to a particularly lethal "wild-type" strain of the virus.

In contrast, a second group of mice that received a more conventional vaccine died within six days of being exposed to the same "wild-type" strain.

"We have a clear roadmap for producing an effective live vaccine against genital herpes," said Halford, who works in MSU's Department of Veterinary Molecular Biology. "Although my studies were performed with HSV-1, the implications for HSV-2-induced genital herpes are clear. Overall the two viruses are about 99 percent genetically identical."

An estimated 55 million Americans carry herpes simplex virus type 2 (HSV-2), which causes genital herpes. Infection is life-long. Approximately 5 percent of those with genital herpes - 2 million to 3 million Americans - suffer outbreaks one to four times annually. A vaccine offering life-long protection does not exist.

The key to Halford's research was understanding how the herpes simplex virus overcame the body's natural defenses.

A cell infected with the herpes simplex virus sends a warning to neighboring cells. This warning -- an interferon response -- causes neighboring cells to enter "an anti-viral state" akin to putting on a suit of armor, Halford said.

However, herpes produces a protein, ICP0, that tricks every infected cell into destroying its own armor. Once the cell's armor is gone, the virus can propagate itself and spread to other cells, which are in turn tricked into lowering their defenses.

In his research, Halford created a vaccine where the genetic instructions that make ICP0 were disrupted. Without instructions on how to do its clever ICP0 trick, the virus can still establish an infection in animals, but the spread of the virus is stopped long before disease can occur.

"In short, we can disarm the virus such that it is absolutely unable to cause disease, but is still remarkably potent as a vaccine," Halford said.

In a human vaccine, the genetic instructions for ICP0 would actually be removed, creating an "attenuated," or weakened virus. The rest of the herpes simplex virus' genetic code would remain intact. Measles, mumps, rubella, polio and yellow fever vaccines are all made from attenuated viruses.

Research in recent decades has focused on subunit vaccines, which are made from one piece of a virus (a protein subunit). Subunit vaccines are safer than attenuated virus vaccines because the subunit cannot replicate or cause disease. However, subunit vaccines have proven ineffective in protecting people against persistent infections like genital herpes and AIDS, Halford said.

"From a theoretical standpoint, subunit vaccines are poor mimics of a natural virus infection," Halford said. "There's not enough there for our immune systems to build a protective response against the actual virus."

Halford, 38, is aware that his approach is controversial.

"This is where I'm young enough that I don't know how long it can take to swing popular opinion among scientists and clinicians," he said. "I would hope that in five to six years the scientific community would be willing to seriously consider these proposals."

Halford hopes to find a commercial partner or secure government funding to advance his research toward a human vaccine.

"I'd like to take this concept from the chalkboard to the clinics," he said.

From Montana State University




Submitted by BJS on Fri, 2006-10-13 13:55.

  • Bio and Medicine


  • Printer-friendly version
  • 17174 reads


It sounds unbelievable

Submitted by Anonymous on Sun, 2008-06-29 00:26.

...but in the case of herpes, it's because most people who have it don't know they have it: they're what are known as asymptomatic carriers. Only a certain percentage of those with herpes would classify themselves as "having an STD" for the simple fact that they don't realise this is the case. But, yes, somewhere between 20% and 25% of adults in the US are believed to be carrying the HSV-2 virus.

  • reply

Companies are Profit Driven

Submitted by Anonymous on Tue, 2008-06-03 14:14.

In regard to Valtrex, the patent runs out in 2009!! Thus we move toward the production of the vaccine. Once the patent runs out they do not make the profit on the medication thus they are motivated to move toward a new patent and vaccine. This vaccine should have been funded years ago. Thank God the patent on Valtrex is running out!!

Has anyone heard an update on funding for the Montana State University vaccine? This is old news (2006 at least) and should have received some funding by now.

  • reply

you're an idiot

Submitted by Anonymous on Fri, 2008-05-23 20:38.

you're an idiot

  • reply

The Cure video > potential cures and vaccines against herpes

Submitted by Anonymous on Sat, 2008-05-17 04:51.

Wanted to share a video I made about potential cures and vaccines against the herpes simplex virus.

http://www.youtube.com/watch?v=71FWd42iKYw

Hope you like it!

/Daniel

  • reply

herpes, VACCINE

Submitted by Anonymous on Fri, 2008-05-16 07:02.

I believe many people are unaware of herpes. People should be informed about how serious it is. One out of five have it. I believe that if more ads were posted in the newspapers, etc. people (teens, men, women)will be informed of this life long STD.

What makes this worst is the fact that when one goes to the hospital, and/or clinic, health care providers don't want to test people for herpes. Why not?

In terms of the vaccine, I agree that those four out of five that dont have it, should be able to take it against this life long STD.

  • reply

it's correct according to my doctor.

Submitted by Anonymous on Wed, 2008-04-16 05:20.

I was recently diagnosed with herpes and was not aware of how common it really is. I was told by a health care professional that stats show that 1 in every 4 are infected with some form of the virus, whether orally or genitally, and are not even aware that that have it, and are spreading it to others. I think more money should go toward educating people on the facts of this virus, and get rid of the "only dirty/slutty people get STD's". I am 22 yeras old and have only been active with two people my entire life, and I got it. The stigma has to go!

The vaccine, for me is too late, but not too late for someone I may fall in love with later down the line. Are the drug companies going to want all this to happen? Probably not, but the millions infected with it already will still have to buy the drugs, so it will be years before they feel an actual hit from it.

  • reply

RIDICULOUS? - 25% infected with STD's

Submitted by Anonymous on Wed, 2008-04-09 23:59.

Why is the statistic so hard to believe? Do you know how many different types of STD's there are out there? HSV alone is estimated to infect 1 out of 5. Then there is HPV which is estimated at 1 out of 4. If we look at the stats for the rest of the most common STDs, I think it would be hard to believe how the overall rate of STD infection is not HIGHER than 25%.

Sex has been so glamourized but STD's have been so demonized (and in the case of AIDS, rightfully demonized) that it is hard to imagine something as beautiful as sex can COMMONLY breed something as ugly as an STD.

  • reply

Vaccine - yes please!!! Take 2

Submitted by Anonymous on Thu, 2008-03-27 19:33.

Oh wait.....they HAVE funded it.

See article on final trials of a Herpes vaccine on this site!

http://www.scienceblog.com/cms/node/2187

  • reply

Vaccine - yes please!!!

Submitted by Anonymous on Thu, 2008-03-27 19:30.

I'm surprised that there aren't yet any pharmaceutical companies (or NIH?) willing to fund further research into an Herpes vaccine. A lot of people would pay good money for this vaccine: there's definitely a commercial market for it!

The Herpes virus is incredibly widely spread throughout most industrialised nations: 30% is commonly agreed to be the infection rate. Seems high, but then, everyone's having sex, so it's really not surprising, especially as condoms don't prevent Herpes infections. We just have to face the reality that 1 in 3 people have or have had an STI. Or stop having sex - like that's gonna happen!

Herpes is more than just unnattractive and uncomfortable. It can cause serious problems in unborn babies, and has been linked to pre-eclampsia (which can kill infant and mother both) and to cervical cancer.

  • reply

The the people who think

Submitted by Anonymous on Thu, 2008-03-27 07:06.

The the people who think companies don't want a vaccine to protect Valtrex profits:

1) Only glaxo-wellcome reaps profits for Valtrex, why wouldn't competing companies want to make a vaccine?

2) Glaxo is currently spending hundreds of millions testing a herpes vaccine, simplirix, which would eat into their Valtrex profits.

3) Valtrex's patent expires in 2009, so your whole theory is based on a false premise.

  • reply

Vaccine query

Submitted by Anonymous on Sun, 2008-03-23 12:26.

Have we heard anymore about the the consideration of this vaccine? It's very interesting. Sadly, there IS more money in the treating of a disease, not the cure.

  • reply

money

Submitted by Anonymous on Wed, 2008-03-19 12:33.

"There are tens of millions that would go for this vaccine, how can he NOT have companies beating down his door?

Every afflicted single person would be buying this vaccine for their SO in a heartbeat."

yes, but there is a limitless supply of money for companies that are selling treatments to the infection, as people must keep buying these over and over. Once a vaccine is made, the pot of money dries up. Unfortunate, but vaccines are not good investments for businesses.

  • reply

New and Improved

Submitted by Anonymous on Wed, 2008-03-05 12:26.

Finding a cure...or even just a vaccine would greatly improve the self-confidence and worth of the nation and the world!!
Can we get one now, please?!

  • reply

That's accurate...

Submitted by Anonymous on Tue, 2008-03-04 08:47.

The stats are accurate. Look them up.

  • reply

herpes stastitics

Submitted by Anonymous on Tue, 2008-03-04 03:29.

I didn't realize it was so common in the US.

  • reply

Although herpes is a wide

Submitted by Anonymous on Mon, 2008-02-25 14:40.

Although herpes is a wide spread disease, your assertion of 1/3 of the population is incorrect.

  • reply

1/3 people living with herpes in USA

Submitted by Anonymous on Thu, 2008-02-21 05:28.

Don't upset by herpes. 1/3 of USA living with herpes. And most of herpes people can manage it.

  • reply

A lot more than 200-400 million are infected

Submitted by Anonymous on Wed, 2008-02-13 11:39.

The number might be closer to 2 000 000 or so.

http://www.anonsolutions.com

  • reply

let me know the dateline of vaccine

Submitted by Anonymous on Tue, 2008-02-12 06:06.

Please let me know the dateline of vaccine. My mail address is ayzobayer@yahoo.com

  • reply

You're honestly trying to

Submitted by Anonymous on Sun, 2008-02-03 13:22.

You're honestly trying to tell us that 70 million of the 300 million people in the US are afflicted with STDs? That's like 1 in every 4 people. A little fucking ridiculous even for something you just made up.

  • reply

reply comments

Submitted by Anonymous on Wed, 2008-01-30 21:19.

"no financial benefit"
- frankly you have no idea what you are talking about. why would one scientist not want to create a vaccine that people want (see below) just because there is a large prevention medication market? they are two different financial interests and the former scientist has everything to gain from creating a vaccine.

"VACCINE."
- i agree.

  • reply

VACCINE.

Submitted by Anonymous0 (not verified) on Thu, 2007-12-20 02:24.

I WILL PAY ANYTHING FOR A HERPES VACCINE.

  • reply

Precaution : < age 13 ,must have knowledg of HSV-2 like AIDS.

Submitted by Anonymous on Sat, 2007-11-10 16:12.

ALL STD DIASES MUST BE AWARE AGE ONWARDS 13. THRE MUST BE WORLD WIDE ADD OF THIS DISES AND OTHER STD LIKE AIDS ADD. IT MUST BE INVOLVED IN EDUCATION LESSION FROM TEENEGERS LESSON. MUCH OF PEOPLE DONT KNOW THAT THERE ARE SOME DIASES/VIRAL INFECTION WHICH CAN TRANSFER BY KISSES OR SEXUAL RELATION WITH CONDOM ALSO....PREVENTION OF THIS CAN AVOIDE ITS EXPAND...THRERE MUST BE MORE RESEARCH TO MAKE HSV-2 VACCINE. for interaction email :-

  • reply

no financial benefit

Submitted by Anonymous on Wed, 2007-10-31 18:52.

There is no financial benefit to curing disease. There are drugs that prevent outbreaks and people are dependent on these drugs. Valtrex will have millions of life long customers. If there were a cure wouldn't drug companies loose billions of dollars?

  • reply

how come it is taking so

Submitted by hillbilly (not verified) on Thu, 2007-06-28 11:40.

how come it is taking so long to find a vaccine for herpes? How come you cant use any type of chemotherapy to destroy it ? or when will there be a vaccine ?

  • reply

std people should the fact and have a positive attitude

Submitted by Anonymous on Sun, 2007-04-01 22:13.

70 million are afflicted with STDs in the U.S. alone and an estimated 200-400 million worldwide.

  • reply

money

Submitted by Anonymous on Fri, 2006-10-13 23:20.

There are tens of millions that would go for this vaccine, how can he NOT have companies beating down his door?

Every afflicted single person would be buying this vaccine for their SO in a heartbeat.

  • reply

Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Allowed HTML tags: <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd> <img> <blockquote>
  • Lines and paragraphs break automatically.

More information about formatting options

Copyright, Science Blog.
Think. It's not illegal yet. Read our Privacy Policy.
RoopleTheme